sacituzumab
gilead
['sacituzumab', 'breast', 'mbc', 'bcsm', 'tropics-02', 'sacitu, govi']
final overall survival (os) analysis from the phase 3 tropics-02 study of sacituzumab govitecan (sg) in patients (pts) with hormone receptor positive/her2-negative (hr+/her2 ) metastatic breast cancer (mbc). summary: #asco23 #bcsm
Cancer Research Patient Advocate at UNC Lineberger CCC. Breast & Liver cancer, clinical trials, PROMs, #SciComm Featured Voice FCOI: https://t.co/PzlQKUfjUw